6:@0.101097:0.957873:0.109688:0.957873:0.109688:0.938882:0.101097:0.938882:0.008591
1:@0.038824:0.186378:0.060302:0.186378:0.060302:0.138900:0.038824:0.138900:0.021478
CHAPTER 1:@0.117647:0.067123:0.186812:0.067123:0.186812:0.047044:0.117647:0.047044:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.004711
Precision medicine and liquid biopsies:@0.117647:0.130507:0.515335:0.130507:0.515335:0.102397:0.117647:0.102397:0.012522:0.013103:0.011069:0.012841:0.006217:0.012144:0.006217:0.013132:0.013626:0.004648:0.017286:0.011069:0.013103:0.006217:0.012841:0.006217:0.013626:0.011069:0.004352:0.012318:0.013626:0.013103:0.004648:0.010285:0.006217:0.013132:0.013015:0.006217:0.013103:0.004648:0.012812:0.006217:0.013132:0.012522:0.012144:0.006217:0.010892:0.012144
The genomic characterization of tumors allows the development of precision cancer :@0.117647:0.175150:0.857052:0.175150:0.857052:0.154777:0.117647:0.154777:0.011470:0.011311:0.009039:0.007396:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.007396:0.008765:0.011391:0.009085:0.007898:0.009291:0.009108:0.006209:0.009039:0.007807:0.005615:0.008834:0.008811:0.006437:0.005547:0.010843:0.011756:0.007396:0.010843:0.006209:0.007396:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.007396:0.009405:0.005385:0.005182:0.010868:0.014723:0.007670:0.007396:0.006620:0.011299:0.009039:0.007396:0.011322:0.009336:0.009633:0.008948:0.005182:0.010820:0.011071:0.017485:0.009039:0.011391:0.006437:0.007396:0.010843:0.006209:0.007396:0.011071:0.007442:0.009108:0.008994:0.005615:0.007601:0.005547:0.010843:0.011756:0.007396:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004109
medicine: matching the best drug or treatment with the right patient based on the specific :@0.117647:0.195728:0.857166:0.195728:0.857166:0.175356:0.117647:0.175356:0.017485:0.009108:0.011391:0.005547:0.008994:0.005615:0.011596:0.009039:0.004497:0.003059:0.017577:0.008811:0.006209:0.008765:0.011459:0.005615:0.011459:0.009861:0.003059:0.006620:0.011299:0.009039:0.003059:0.011254:0.009039:0.007510:0.006437:0.003059:0.011391:0.007967:0.011413:0.009861:0.003059:0.010843:0.007807:0.003059:0.006437:0.007442:0.009288:0.008813:0.006437:0.017485:0.009039:0.011391:0.006437:0.003059:0.014723:0.005273:0.006620:0.011459:0.003059:0.006620:0.011302:0.009039:0.003059:0.007807:0.005615:0.009930:0.011094:0.006437:0.003059:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.003059:0.011117:0.009291:0.007873:0.009108:0.011391:0.003059:0.010843:0.011756:0.003059:0.006620:0.011302:0.009039:0.003059:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005613:0.008994:0.004109
mutations present in the tumor:@0.117647:0.216307:0.386275:0.216307:0.386275:0.195934:0.117647:0.195934:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.005615:0.011071:0.007442:0.009039:0.007875:0.009039:0.011391:0.006437:0.005615:0.005615:0.011756:0.005615:0.006620:0.011302:0.009039:0.005615:0.006163:0.011413:0.017485:0.010843:0.007807
37–42:@0.386244:0.208691:0.417451:0.208691:0.417451:0.196814:0.386244:0.196814:0.006082:0.006082:0.006880:0.006082:0.006082
. Moreover, the combination of different mutations :@0.417450:0.216307:0.857094:0.216307:0.857094:0.195934:0.417450:0.195934:0.004497:0.005615:0.018969:0.010843:0.007442:0.009108:0.010866:0.009633:0.009039:0.006255:0.004497:0.005615:0.006617:0.011302:0.009039:0.005615:0.008994:0.010845:0.017394:0.010820:0.005615:0.011687:0.008811:0.006437:0.005547:0.010843:0.011756:0.005615:0.010840:0.006209:0.005615:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.005615:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004109
or the overall mutational landscape of a tumor -also known as mutational signatures - :@0.117647:0.236886:0.857050:0.236886:0.857050:0.216513:0.117647:0.216513:0.010843:0.007807:0.004976:0.006620:0.011299:0.009039:0.004976:0.010866:0.009633:0.009039:0.007898:0.009405:0.005387:0.005250:0.004976:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011687:0.009405:0.005250:0.004976:0.005433:0.009085:0.011596:0.011391:0.007875:0.009108:0.008811:0.011505:0.009039:0.004976:0.010843:0.006209:0.004976:0.009291:0.004976:0.006163:0.011413:0.017485:0.010843:0.007807:0.004976:0.007533:0.009405:0.005250:0.007875:0.011048:0.004976:0.010706:0.011596:0.010866:0.014723:0.011756:0.004976:0.009291:0.007670:0.004976:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011687:0.009405:0.005250:0.004976:0.007601:0.005615:0.009861:0.011687:0.008811:0.006163:0.011413:0.007442:0.009039:0.007670:0.012279:0.007533:0.004109
43:@0.833245:0.229270:0.845409:0.229270:0.845409:0.217392:0.833245:0.217392:0.006082:0.006082
can only be discovered with WGS and also provides therapeutic opportunities:@0.117647:0.257465:0.776926:0.257465:0.776926:0.237092:0.117647:0.237092:0.009108:0.009085:0.011756:0.004565:0.010843:0.011870:0.005182:0.009724:0.004565:0.011251:0.009039:0.004565:0.011391:0.005615:0.007875:0.008994:0.010866:0.009633:0.009039:0.007442:0.009108:0.011391:0.004565:0.014723:0.005273:0.006620:0.011459:0.004565:0.020270:0.015682:0.010112:0.004565:0.009085:0.011596:0.011391:0.004565:0.009405:0.005250:0.007875:0.011048:0.004565:0.011071:0.007442:0.010866:0.009838:0.005547:0.011322:0.009039:0.007670:0.004565:0.006620:0.011299:0.009039:0.007898:0.008811:0.011502:0.009131:0.011071:0.006437:0.005547:0.008994:0.004565:0.010820:0.011048:0.011505:0.010843:0.007967:0.006163:0.011413:0.011756:0.005273:0.006437:0.005547:0.009039:0.007670
44–46:@0.776947:0.249849:0.808154:0.249849:0.808154:0.237971:0.776947:0.237971:0.006082:0.006082:0.006880:0.006082:0.006082
. Our :@0.808153:0.257465:0.857048:0.257465:0.857048:0.237092:0.808153:0.237092:0.004497:0.004565:0.016504:0.011413:0.007807:0.004109
knowledge of new actionable alterations evolves rapidly, therefore the comprehensiveness :@0.117647:0.278043:0.857034:0.278043:0.857034:0.257670:0.117647:0.257670:0.010706:0.011596:0.010866:0.014792:0.005182:0.009108:0.011391:0.009656:0.009039:0.002534:0.010843:0.006209:0.002534:0.011596:0.009336:0.014723:0.002534:0.009291:0.009108:0.006437:0.005547:0.010843:0.011687:0.009108:0.010913:0.005182:0.009039:0.002534:0.009405:0.004908:0.006209:0.009039:0.007898:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.002534:0.009336:0.009633:0.010934:0.005182:0.009635:0.009039:0.007670:0.002534:0.007896:0.008811:0.011071:0.005547:0.011528:0.005182:0.007989:0.004497:0.002534:0.006620:0.011299:0.009039:0.007442:0.009039:0.006026:0.010843:0.007442:0.009039:0.002534:0.006620:0.011299:0.009039:0.002534:0.008994:0.010843:0.017282:0.011071:0.007442:0.008948:0.011299:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.011596:0.009039:0.007533:0.007670:0.004109
of WGS is also essential to be able to reassess data with new knowledge. Particularly, :@0.117647:0.298622:0.857007:0.298622:0.857007:0.278249:0.117647:0.278249:0.010843:0.006209:0.006528:0.020268:0.015682:0.010112:0.006528:0.005615:0.007670:0.006528:0.009405:0.005250:0.007875:0.011048:0.006528:0.009039:0.007533:0.007875:0.009039:0.011391:0.006437:0.005798:0.009405:0.005250:0.006528:0.006211:0.011048:0.006528:0.011254:0.009039:0.006528:0.009108:0.010911:0.005182:0.009039:0.006528:0.006209:0.011048:0.006528:0.007442:0.009291:0.009291:0.007533:0.007875:0.009039:0.007533:0.007670:0.006528:0.011573:0.008811:0.006551:0.009291:0.006528:0.014723:0.005273:0.006620:0.011459:0.006528:0.011596:0.009336:0.014723:0.006528:0.010706:0.011596:0.010866:0.014792:0.005182:0.009108:0.011391:0.009656:0.008743:0.004497:0.006528:0.011413:0.009085:0.007967:0.006437:0.005547:0.009106:0.011550:0.005433:0.009085:0.007601:0.005182:0.007992:0.004497:0.004109
clinical trials can be designed based on particular cancer alterations rather than cancer :@0.117647:0.319201:0.856963:0.319201:0.856963:0.298828:0.117647:0.298828:0.008765:0.005250:0.005615:0.011756:0.005547:0.009108:0.009405:0.005250:0.005136:0.006437:0.007807:0.005798:0.009405:0.005250:0.007670:0.005136:0.009108:0.009085:0.011756:0.005136:0.011251:0.009039:0.005136:0.011322:0.009039:0.007601:0.005615:0.009861:0.011596:0.009108:0.011391:0.005136:0.011117:0.009291:0.007875:0.009108:0.011391:0.005136:0.010843:0.011756:0.005136:0.011368:0.009085:0.007967:0.006437:0.005547:0.009108:0.011550:0.005433:0.009085:0.007807:0.005136:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.005136:0.009405:0.004908:0.006209:0.009039:0.007898:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.005136:0.007898:0.008811:0.006620:0.011299:0.009039:0.007807:0.005136:0.006620:0.011393:0.009085:0.011756:0.005136:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004109
type to increase sample sizes, which is particularly relevant to rare cancer types:@0.117647:0.339779:0.766838:0.339779:0.766838:0.319406:0.117647:0.319406:0.006437:0.009724:0.011505:0.009039:0.003447:0.006209:0.011048:0.003447:0.005615:0.011596:0.008994:0.007442:0.009291:0.009291:0.007875:0.009039:0.003447:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.003447:0.007601:0.005615:0.008834:0.009039:0.007670:0.004497:0.003447:0.014792:0.011459:0.005547:0.008765:0.011459:0.003447:0.005615:0.007670:0.003447:0.011368:0.009085:0.007967:0.006437:0.005547:0.009108:0.011550:0.005433:0.009085:0.007601:0.005182:0.009724:0.003447:0.007442:0.008948:0.005182:0.009336:0.009838:0.009085:0.011391:0.006437:0.003447:0.006209:0.011048:0.003447:0.007898:0.009085:0.007442:0.009039:0.003447:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.003447:0.006437:0.009724:0.011502:0.009039:0.007670
35,47:@0.766785:0.332163:0.793734:0.332163:0.793734:0.320286:0.766785:0.320286:0.006082:0.006082:0.002622:0.006082:0.006082
. Other :@0.793733:0.339779:0.857054:0.339779:0.857054:0.319406:0.793733:0.319406:0.004497:0.003447:0.016504:0.006620:0.011299:0.009039:0.007807:0.004109
advantages of WGS implementation are the identification of secondary or multiple :@0.117647:0.360358:0.857007:0.360358:0.857007:0.339985:0.117647:0.339985:0.009291:0.011322:0.009838:0.009085:0.011391:0.006551:0.009199:0.009656:0.009039:0.007670:0.008355:0.010843:0.006209:0.008355:0.020270:0.015682:0.010112:0.008355:0.005615:0.017280:0.011162:0.005182:0.009039:0.017485:0.009039:0.011391:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.008355:0.009087:0.007442:0.009039:0.008355:0.006620:0.011299:0.009039:0.008355:0.005545:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.008355:0.010843:0.006209:0.008355:0.007875:0.009108:0.008994:0.010843:0.011596:0.011573:0.009085:0.008400:0.009724:0.008355:0.010843:0.007807:0.008355:0.017280:0.011550:0.004908:0.006437:0.005273:0.011162:0.005182:0.009039:0.004109
alterations to counterpart acquired resistance that emerge after prolonged cancer :@0.117647:0.380937:0.857032:0.380937:0.857032:0.360564:0.117647:0.360564:0.009405:0.004908:0.006209:0.009039:0.007898:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.010729:0.006209:0.011048:0.010729:0.008994:0.010820:0.011413:0.011391:0.006209:0.009039:0.007967:0.011368:0.009085:0.007967:0.006437:0.010729:0.009291:0.008994:0.010706:0.011413:0.005615:0.007442:0.009108:0.011391:0.010729:0.007442:0.009039:0.007601:0.005615:0.007510:0.006549:0.009087:0.011596:0.008994:0.009039:0.010729:0.006620:0.011391:0.008811:0.006437:0.010729:0.009039:0.017485:0.009039:0.007624:0.009656:0.009039:0.010729:0.009085:0.006197:0.005969:0.009039:0.007807:0.010729:0.011071:0.007442:0.010934:0.005182:0.010843:0.011459:0.009658:0.009106:0.011391:0.010729:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.004109
therapies:@0.117647:0.401515:0.194642:0.401515:0.194642:0.381143:0.117647:0.381143:0.006620:0.011299:0.009039:0.007898:0.008811:0.011071:0.005547:0.009039:0.007670
35,48:@0.194642:0.393899:0.221590:0.393899:0.221590:0.382022:0.194642:0.382022:0.006082:0.006082:0.002622:0.006082:0.006082
 and the application in cancer immunotherapy and antitumor activity of the :@0.221589:0.401515:0.856970:0.401515:0.856970:0.381143:0.221589:0.381143:0.003858:0.009085:0.011596:0.011391:0.003858:0.006620:0.011299:0.009039:0.003858:0.008811:0.011046:0.011162:0.005250:0.005547:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.003858:0.005615:0.011756:0.003858:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.003858:0.005615:0.017645:0.017278:0.011413:0.011598:0.010820:0.006617:0.011302:0.009039:0.007896:0.008811:0.011094:0.009724:0.003858:0.009085:0.011596:0.011391:0.003858:0.009085:0.011391:0.006437:0.005273:0.006163:0.011413:0.017485:0.010843:0.007807:0.003858:0.009291:0.009108:0.006437:0.005547:0.009838:0.005273:0.006437:0.009724:0.003858:0.010843:0.006209:0.003858:0.006620:0.011299:0.009039:0.004109
patients’ own immune system through tumor-specific neoantigen prediction:@0.117647:0.422094:0.759737:0.422094:0.759737:0.401721:0.117647:0.401721:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.006277:0.004291:0.004109:0.010866:0.014723:0.011756:0.004109:0.005615:0.017645:0.017278:0.011413:0.011598:0.009039:0.004109:0.007759:0.009724:0.007510:0.006209:0.009039:0.017645:0.004109:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011459:0.004109:0.006163:0.011413:0.017485:0.010843:0.007236:0.007533:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005615:0.008994:0.004109:0.011596:0.009108:0.011137:0.009087:0.011391:0.006437:0.005615:0.009653:0.009039:0.011756:0.004109:0.011071:0.007442:0.009108:0.011391:0.005547:0.009108:0.006437:0.005547:0.010843:0.011756
49,50:@0.759737:0.414478:0.786686:0.414478:0.786686:0.402601:0.759737:0.402601:0.006082:0.006082:0.002622:0.006082:0.006082
.:@0.786685:0.422094:0.791182:0.422094:0.791182:0.401721:0.786685:0.401721:0.004497
Specific molecular profiling of each tumor is key for the development and application :@0.117647:0.463252:0.857068:0.463252:0.857068:0.442879:0.117647:0.442879:0.009793:0.011505:0.009108:0.008994:0.005615:0.005684:0.005615:0.008994:0.005866:0.017485:0.010934:0.005182:0.009108:0.009108:0.011548:0.005433:0.009085:0.007807:0.005866:0.011071:0.007442:0.010843:0.005684:0.005821:0.005250:0.005615:0.011459:0.009861:0.005866:0.010843:0.006209:0.005866:0.009291:0.009291:0.008765:0.011459:0.005866:0.006163:0.011413:0.017485:0.010843:0.007807:0.005866:0.005615:0.007670:0.005866:0.010274:0.009334:0.009724:0.005866:0.006024:0.010843:0.007807:0.005866:0.006620:0.011299:0.009039:0.005866:0.011322:0.009336:0.009633:0.008948:0.005182:0.010820:0.011071:0.017485:0.009039:0.011391:0.006437:0.005866:0.009085:0.011598:0.011391:0.005866:0.008811:0.011048:0.011160:0.005250:0.005545:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.004109
of precision oncology. Often, access to tumor material to perform WGS or other :@0.117647:0.483830:0.857009:0.483830:0.857009:0.463457:0.117647:0.463457:0.010843:0.006209:0.009519:0.011071:0.007442:0.009108:0.008994:0.005615:0.007601:0.005547:0.010845:0.011756:0.009519:0.010843:0.011596:0.008994:0.010934:0.005182:0.011048:0.010546:0.007989:0.004497:0.009519:0.016298:0.006197:0.005969:0.009039:0.011756:0.004497:0.009519:0.009291:0.008994:0.008994:0.009039:0.007533:0.007670:0.009519:0.006209:0.011048:0.009519:0.006163:0.011413:0.017485:0.010843:0.007807:0.009519:0.017579:0.008809:0.006211:0.009039:0.007807:0.005796:0.009405:0.005250:0.009519:0.006209:0.011048:0.009519:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017645:0.009519:0.020270:0.015682:0.010112:0.009519:0.010843:0.007807:0.009519:0.010820:0.006620:0.011299:0.009039:0.007807:0.004109
analyses is limited and depends on invasive procedures. There is therefore an increasing :@0.117647:0.504409:0.857025:0.504409:0.857025:0.484036:0.117647:0.484036:0.009085:0.011687:0.009405:0.005182:0.009724:0.007875:0.009039:0.007670:0.004383:0.005615:0.007670:0.004383:0.005250:0.005615:0.017645:0.005271:0.006209:0.009108:0.011391:0.004383:0.009085:0.011596:0.011391:0.004383:0.011322:0.009131:0.011505:0.009039:0.011596:0.011391:0.007670:0.004383:0.010843:0.011756:0.004383:0.005615:0.011368:0.009838:0.009291:0.007601:0.005547:0.009633:0.009039:0.004383:0.011071:0.007442:0.011276:0.008994:0.009106:0.011048:0.011413:0.007442:0.009039:0.007670:0.004497:0.004383:0.011470:0.011311:0.009039:0.007442:0.009039:0.004383:0.005615:0.007670:0.004383:0.006620:0.011299:0.009039:0.007442:0.009039:0.006026:0.010843:0.007442:0.009039:0.004383:0.009085:0.011756:0.004383:0.005615:0.011596:0.008994:0.007442:0.009291:0.009291:0.007601:0.005615:0.011459:0.009861:0.004109
focus in oncology towards liquid biopsies, which are methods that analyze blood or :@0.117647:0.524988:0.857096:0.524988:0.857096:0.504615:0.117647:0.504615:0.006026:0.011276:0.009108:0.011413:0.007670:0.007190:0.005615:0.011756:0.007190:0.010843:0.011598:0.008994:0.010932:0.005184:0.011048:0.010544:0.009724:0.007190:0.006209:0.010866:0.014723:0.009085:0.007442:0.011391:0.007670:0.007190:0.005250:0.005547:0.010706:0.011413:0.005547:0.011391:0.007190:0.010820:0.005547:0.010820:0.011185:0.007601:0.005547:0.009039:0.007670:0.004497:0.007190:0.014789:0.011459:0.005547:0.008765:0.011459:0.007190:0.009085:0.007442:0.009039:0.007190:0.017485:0.009131:0.006620:0.011299:0.011276:0.011391:0.007670:0.007190:0.006622:0.011388:0.008811:0.006437:0.007190:0.009085:0.011687:0.009405:0.005182:0.009724:0.008834:0.009039:0.007190:0.010911:0.005182:0.011276:0.011276:0.011391:0.007190:0.010843:0.007807:0.004109
other  biological  fluids  to derive  cancer  diagnostic  information:@0.117647:0.545566:0.661769:0.545566:0.661769:0.525193:0.117647:0.525193:0.010820:0.006620:0.011299:0.009039:0.007807:0.004109:0.003504:0.010820:0.005547:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.004109:0.003504:0.005638:0.005296:0.011413:0.005547:0.011391:0.007670:0.004109:0.003504:0.006209:0.011048:0.007624:0.011322:0.009039:0.007807:0.005547:0.009633:0.009039:0.004109:0.003504:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004109:0.003504:0.011391:0.005798:0.009199:0.009861:0.011596:0.010957:0.007510:0.006437:0.005547:0.008994:0.004109:0.003504:0.005615:0.011756:0.006026:0.010843:0.007807:0.017577:0.008811:0.006437:0.005547:0.010843:0.011756
51–53:@0.661762:0.537950:0.692969:0.537950:0.692969:0.526073:0.661762:0.526073:0.006082:0.006082:0.006880:0.006082:0.006082
.  Due  to  their  low :@0.692968:0.545566:0.857049:0.545566:0.857049:0.525193:0.692968:0.525193:0.004497:0.004109:0.003504:0.016230:0.011345:0.009039:0.004109:0.003504:0.006211:0.011048:0.004109:0.003504:0.006620:0.011299:0.009039:0.005615:0.007807:0.004109:0.003504:0.005182:0.010866:0.014723:0.004109
invasiveness, they can be repeated at multiple time points with less inconvenience for the :@0.117647:0.566145:0.857029:0.566145:0.857029:0.545772:0.117647:0.545772:0.005615:0.011368:0.009838:0.009291:0.007601:0.005547:0.009633:0.009039:0.011596:0.009039:0.007533:0.007670:0.004497:0.003584:0.006620:0.011299:0.009336:0.009724:0.003584:0.009108:0.009085:0.011756:0.003584:0.011254:0.009039:0.003584:0.007442:0.009131:0.011502:0.009291:0.008811:0.006209:0.009108:0.011391:0.003584:0.008811:0.006437:0.003584:0.017280:0.011550:0.004908:0.006437:0.005271:0.011162:0.005182:0.009039:0.003584:0.006437:0.005615:0.017485:0.009039:0.003584:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.003584:0.014723:0.005273:0.006620:0.011459:0.003584:0.005182:0.009039:0.007533:0.007670:0.003584:0.005615:0.011598:0.008994:0.010843:0.011368:0.009633:0.009039:0.011756:0.005547:0.009039:0.011596:0.008994:0.009039:0.003584:0.006026:0.010845:0.007807:0.003584:0.006620:0.011299:0.009039:0.004109
patient. There are different analytes that can be investigated in liquid biopsies: circulating :@0.117647:0.586724:0.857048:0.586724:0.857048:0.566351:0.117647:0.566351:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.004497:0.003618:0.011470:0.011311:0.009039:0.007442:0.009039:0.003618:0.009085:0.007442:0.009039:0.003618:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.003618:0.009085:0.011687:0.009405:0.005182:0.009724:0.006209:0.009039:0.007670:0.003618:0.006620:0.011391:0.008811:0.006437:0.003618:0.009108:0.009085:0.011756:0.003618:0.011254:0.009039:0.003618:0.005615:0.011368:0.009633:0.009039:0.007510:0.006437:0.005615:0.009861:0.008811:0.006209:0.009106:0.011391:0.003618:0.005615:0.011756:0.003618:0.005250:0.005547:0.010706:0.011413:0.005547:0.011391:0.003618:0.010820:0.005547:0.010820:0.011185:0.007601:0.005547:0.009039:0.007670:0.004497:0.003618:0.008994:0.005615:0.007442:0.009108:0.011550:0.005430:0.008811:0.006437:0.005615:0.011459:0.009861:0.004109
tumor cells (CTCs), circulating tumor DNA (ctDNA), extracellular vesicles or tumor-:@0.117647:0.607302:0.853012:0.607302:0.853012:0.586930:0.117647:0.586930:0.006163:0.011413:0.017485:0.010843:0.007807:0.006003:0.008994:0.008948:0.005387:0.005250:0.007670:0.006003:0.006939:0.014678:0.013057:0.014678:0.007670:0.006939:0.004497:0.006003:0.008994:0.005615:0.007442:0.009108:0.011550:0.005433:0.008809:0.006437:0.005615:0.011459:0.009861:0.006003:0.006163:0.011413:0.017485:0.010843:0.007807:0.006003:0.015773:0.015408:0.014929:0.006003:0.006939:0.009108:0.006437:0.015773:0.015408:0.014929:0.006939:0.004497:0.006003:0.009108:0.010089:0.006437:0.007898:0.009291:0.008994:0.008948:0.005387:0.004908:0.011550:0.005433:0.009085:0.007807:0.006003:0.009633:0.009039:0.007601:0.005547:0.008765:0.005182:0.009039:0.007670:0.006003:0.010843:0.007807:0.006003:0.006166:0.011413:0.017485:0.010843:0.007236:0.007533
educated platelets . ctDNA are DNA molecules that are released to the bloodstream :@0.117647:0.627881:0.856965:0.627881:0.856965:0.607508:0.117647:0.607508:0.009108:0.011048:0.011345:0.009108:0.008811:0.006209:0.009106:0.011391:0.006894:0.011162:0.005433:0.008811:0.006209:0.008948:0.005182:0.009131:0.006437:0.007670:0.012173:0.004497:0.006894:0.009108:0.006437:0.015773:0.015408:0.014929:0.006894:0.009085:0.007444:0.009039:0.006894:0.015773:0.015408:0.014929:0.006894:0.017485:0.010934:0.005182:0.009108:0.009108:0.011550:0.005182:0.009039:0.007670:0.006894:0.006620:0.011391:0.008811:0.006437:0.006894:0.009085:0.007442:0.009039:0.006894:0.007442:0.008948:0.005182:0.009291:0.009291:0.007873:0.009108:0.011391:0.006894:0.006209:0.011048:0.006894:0.006620:0.011299:0.009039:0.006894:0.010911:0.005182:0.011276:0.011276:0.011391:0.007510:0.006437:0.007442:0.009291:0.009085:0.017645:0.004109
51:@0.269658:0.620265:0.281822:0.620265:0.281822:0.608388:0.269658:0.608388:0.006082:0.006082
by dying cancer cells. These ctDNA fragments reflect comprehensively the genome of :@0.117647:0.648460:0.857050:0.648460:0.857050:0.628087:0.117647:0.628087:0.010843:0.009724:0.006127:0.011322:0.009724:0.005615:0.011459:0.009861:0.006129:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.006127:0.008994:0.008948:0.005387:0.005250:0.007670:0.004497:0.006127:0.011470:0.011313:0.009039:0.007873:0.009039:0.006129:0.009108:0.006437:0.015773:0.015408:0.014929:0.006127:0.006414:0.007898:0.009199:0.009861:0.017485:0.009039:0.011391:0.006437:0.007670:0.006127:0.007442:0.009039:0.005638:0.005570:0.009108:0.009108:0.006437:0.006127:0.008994:0.010843:0.017280:0.011071:0.007442:0.008948:0.011302:0.009039:0.011619:0.007604:0.005545:0.009635:0.008948:0.005182:0.009724:0.006127:0.006620:0.011299:0.009039:0.006129:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.006127:0.010843:0.006209:0.004109
the tumor including SNVs, SVs and even other epigenomic alterations:@0.117647:0.669039:0.710306:0.669039:0.710306:0.648666:0.117647:0.648666:0.006620:0.011299:0.009039:0.004485:0.006163:0.011413:0.017485:0.010843:0.007807:0.004485:0.005615:0.011596:0.008765:0.004908:0.011345:0.011391:0.005615:0.011459:0.009861:0.004485:0.009768:0.016230:0.015089:0.007670:0.004497:0.004485:0.010112:0.015089:0.007670:0.004485:0.009085:0.011596:0.011391:0.004485:0.009336:0.009633:0.009039:0.011756:0.004485:0.010820:0.006620:0.011299:0.009039:0.007807:0.004483:0.009131:0.011071:0.005615:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.004485:0.009405:0.004908:0.006209:0.009039:0.007898:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670
53–55:@0.710305:0.661423:0.741512:0.661423:0.741512:0.649545:0.710305:0.649545:0.006082:0.006082:0.006880:0.006082:0.006082
 (:@0.741511:0.669039:0.752936:0.669039:0.752936:0.648666:0.741511:0.648666:0.004485:0.006939
Figure 2A:@0.752936:0.669039:0.841503:0.669039:0.841503:0.647906:0.752936:0.647906:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004383:0.010911:0.015089
). :@0.841505:0.669039:0.857050:0.669039:0.857050:0.648666:0.841505:0.648666:0.006939:0.004497:0.004109
Although apoptotic or necrotic normal cells also release their genomic content to the :@0.117647:0.689617:0.857144:0.689617:0.857144:0.669244:0.117647:0.669244:0.015066:0.004908:0.006620:0.011299:0.010820:0.011413:0.009930:0.011459:0.006209:0.008811:0.011505:0.010820:0.011048:0.006209:0.010820:0.006437:0.005547:0.008994:0.006209:0.010843:0.007807:0.006209:0.011596:0.009108:0.008994:0.007442:0.010820:0.006437:0.005547:0.008994:0.006209:0.011596:0.010843:0.007807:0.017577:0.009405:0.005250:0.006209:0.008994:0.008948:0.005387:0.005250:0.007670:0.006209:0.009405:0.005250:0.007873:0.011048:0.006209:0.007442:0.008948:0.005182:0.009291:0.009291:0.007875:0.009039:0.006209:0.006620:0.011299:0.009039:0.005615:0.007807:0.006209:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.006209:0.008994:0.010843:0.011391:0.006209:0.009039:0.011391:0.006437:0.006209:0.006209:0.011048:0.006209:0.006620:0.011302:0.009039:0.004109
bloodstream (cell-free DNA, cfDNA) ctDNA molecules show a shorter size distribution :@0.117647:0.710196:0.856959:0.710196:0.856959:0.689823:0.117647:0.689823:0.010911:0.005182:0.011276:0.011276:0.011391:0.007510:0.006437:0.007442:0.009291:0.009085:0.017645:0.004063:0.006939:0.008994:0.008948:0.005387:0.005250:0.007533:0.006412:0.007442:0.009108:0.009039:0.004063:0.015773:0.015408:0.014929:0.004497:0.004063:0.008994:0.006209:0.015773:0.015408:0.014929:0.006939:0.004063:0.009108:0.006437:0.015773:0.015408:0.014929:0.004063:0.017485:0.010934:0.005182:0.009108:0.009108:0.011548:0.005184:0.009039:0.007670:0.004063:0.007556:0.011299:0.010866:0.014723:0.004063:0.009291:0.004063:0.007556:0.011299:0.010843:0.007967:0.006209:0.009039:0.007807:0.004063:0.007601:0.005615:0.008834:0.009039:0.004063:0.011391:0.005615:0.007510:0.006437:0.007807:0.005547:0.010797:0.011071:0.006437:0.005547:0.010843:0.011756:0.004109
than normal cfDNA for unclear reasons. The tumor-specific mutations can be detected :@0.117647:0.730775:0.857137:0.730775:0.857137:0.710402:0.117647:0.710402:0.006620:0.011391:0.009085:0.011756:0.004839:0.011596:0.010843:0.007807:0.017577:0.009405:0.005250:0.004839:0.008994:0.006209:0.015773:0.015408:0.014929:0.004839:0.006026:0.010843:0.007807:0.004839:0.011413:0.011596:0.008765:0.005182:0.009291:0.009085:0.007807:0.004839:0.007442:0.009291:0.009291:0.007875:0.010843:0.011619:0.007670:0.004497:0.004839:0.011470:0.011311:0.009039:0.004839:0.006163:0.011413:0.017485:0.010843:0.007236:0.007533:0.007510:0.011502:0.009108:0.008994:0.005615:0.005684:0.005615:0.008994:0.004839:0.017280:0.011071:0.006549:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004839:0.009108:0.009085:0.011756:0.004839:0.011254:0.009039:0.004839:0.011322:0.009128:0.006211:0.009106:0.009108:0.006209:0.009108:0.011391:0.004109
from ctDNA by sequencing or with other sensitive approaches like digital-droplet :@0.117647:0.751353:0.857068:0.751353:0.857068:0.730981:0.117647:0.730981:0.006414:0.007442:0.010843:0.017645:0.009245:0.009108:0.006437:0.015773:0.015408:0.014929:0.009245:0.010843:0.009724:0.009245:0.007875:0.009106:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.009245:0.010840:0.007807:0.009245:0.014723:0.005271:0.006620:0.011459:0.009245:0.010820:0.006620:0.011299:0.009039:0.007807:0.009245:0.007875:0.009039:0.011619:0.007601:0.005273:0.006437:0.005547:0.009633:0.009039:0.009245:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011299:0.009039:0.007670:0.009245:0.005250:0.005752:0.010272:0.009039:0.009245:0.011391:0.005615:0.009861:0.005273:0.006551:0.009405:0.005250:0.007533:0.011391:0.007442:0.010820:0.011162:0.005182:0.009131:0.006437:0.004109
PCR. Intra- and inter-tumor heterogeneity and clonality are also reflected in ctDNA . :@0.117647:0.771932:0.857050:0.771932:0.857050:0.751559:0.117647:0.751559:0.012167:0.014678:0.013696:0.004497:0.005547:0.006894:0.011391:0.006437:0.007898:0.009291:0.007533:0.005547:0.009085:0.011596:0.011391:0.005547:0.005615:0.011391:0.006209:0.009039:0.007236:0.007533:0.006163:0.011413:0.017485:0.010843:0.007807:0.005547:0.011299:0.009131:0.006209:0.009039:0.007442:0.011048:0.009656:0.009039:0.011596:0.009039:0.005273:0.006437:0.009724:0.005547:0.009085:0.011596:0.011391:0.005547:0.008765:0.005182:0.010843:0.011687:0.009405:0.005250:0.005273:0.006437:0.009724:0.005547:0.009085:0.007442:0.009039:0.005547:0.009402:0.005250:0.007875:0.011048:0.005547:0.007442:0.009039:0.005638:0.005567:0.009108:0.009108:0.006209:0.009108:0.011391:0.005547:0.005615:0.011756:0.005547:0.009108:0.006437:0.015773:0.015408:0.014929:0.012146:0.004497:0.004109
56:@0.836281:0.764316:0.848445:0.764316:0.848445:0.752439:0.836281:0.752439:0.006082:0.006082
There is a linear relationship between variant allele frequency (VAF) as found in ctDNA :@0.117647:0.792511:0.857050:0.792511:0.857050:0.772138:0.117647:0.772138:0.011470:0.011311:0.009039:0.007442:0.009039:0.004360:0.005615:0.007670:0.004360:0.009291:0.004360:0.005250:0.005615:0.011596:0.009291:0.009085:0.007807:0.004360:0.007442:0.008948:0.005433:0.008811:0.006437:0.005547:0.010843:0.011619:0.007556:0.011459:0.005273:0.011276:0.004360:0.011251:0.009131:0.006437:0.014518:0.009108:0.009039:0.011756:0.004360:0.009838:0.009085:0.007807:0.005798:0.009085:0.011391:0.006437:0.004360:0.009405:0.005387:0.005182:0.008948:0.005182:0.009039:0.004360:0.006414:0.007442:0.009108:0.010706:0.011345:0.009039:0.011596:0.009382:0.009724:0.004360:0.006825:0.012578:0.014929:0.011368:0.006939:0.004360:0.009291:0.007670:0.004360:0.006026:0.010820:0.011413:0.011596:0.011391:0.004360:0.005615:0.011756:0.004360:0.009108:0.006437:0.015773:0.015408:0.014929:0.004109
and tumor mass or load:@0.117647:0.813090:0.325531:0.813090:0.325531:0.792717:0.117647:0.792717:0.009085:0.011596:0.011391:0.006095:0.006163:0.011413:0.017485:0.010843:0.007807:0.006095:0.017577:0.009291:0.007533:0.007670:0.006095:0.010843:0.007807:0.006095:0.005182:0.011139:0.009291:0.011391
57–59:@0.325515:0.805473:0.356722:0.805473:0.356722:0.793596:0.325515:0.793596:0.006082:0.006082:0.006880:0.006082:0.006082
. Furthermore, ctDNA has been found to have prognostic :@0.356721:0.813090:0.857084:0.813090:0.857084:0.792717:0.356721:0.792717:0.004497:0.006095:0.010729:0.011413:0.007967:0.006620:0.011299:0.009039:0.007807:0.017485:0.010843:0.007442:0.008743:0.004497:0.006095:0.009108:0.006437:0.015773:0.015408:0.014929:0.006095:0.011391:0.009291:0.007670:0.006095:0.011254:0.009108:0.009039:0.011756:0.006095:0.006026:0.010820:0.011413:0.011596:0.011391:0.006095:0.006209:0.011048:0.006095:0.011391:0.008925:0.009633:0.009039:0.006095:0.011071:0.007442:0.011048:0.009861:0.011596:0.010957:0.007510:0.006437:0.005547:0.008994:0.004109
value in clinical trials:@0.117647:0.833668:0.302610:0.833668:0.302610:0.813295:0.117647:0.813295:0.009838:0.009405:0.004908:0.011345:0.009039:0.006665:0.005615:0.011756:0.006665:0.008765:0.005250:0.005615:0.011756:0.005547:0.009108:0.009405:0.005250:0.006665:0.006437:0.007807:0.005798:0.009402:0.005250:0.007670
60,61:@0.302590:0.826052:0.329539:0.826052:0.329539:0.814175:0.302590:0.814175:0.006082:0.006082:0.002622:0.006082:0.006082
. The main applications of liquid biopsies are early diagnosis :@0.329538:0.833668:0.857111:0.833668:0.857111:0.813295:0.329538:0.813295:0.004497:0.006665:0.011470:0.011311:0.009039:0.006665:0.017577:0.009085:0.005615:0.011756:0.006665:0.008811:0.011048:0.011162:0.005250:0.005547:0.009108:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.006665:0.010843:0.006209:0.006665:0.005250:0.005547:0.010706:0.011413:0.005547:0.011391:0.006665:0.010820:0.005547:0.010820:0.011185:0.007601:0.005547:0.009039:0.007670:0.006665:0.009085:0.007442:0.009039:0.006665:0.009291:0.009085:0.007601:0.005182:0.009724:0.006665:0.011391:0.005798:0.009199:0.009861:0.011596:0.010957:0.007601:0.005615:0.007670:0.004109
of cancer:@0.117647:0.854247:0.198431:0.854247:0.198431:0.833874:0.117647:0.833874:0.010843:0.006209:0.008104:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807
62,63:@0.198431:0.846631:0.225380:0.846631:0.225380:0.834753:0.198431:0.834753:0.006082:0.006082:0.002622:0.006082:0.006082
, treatment selection and monitoring:@0.225379:0.854247:0.549086:0.854247:0.549086:0.833874:0.225379:0.833874:0.004497:0.008104:0.006437:0.007442:0.009291:0.008811:0.006437:0.017485:0.009039:0.011391:0.006437:0.008104:0.007875:0.008948:0.005182:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.008104:0.009085:0.011596:0.011391:0.008104:0.017488:0.010840:0.011756:0.005273:0.006209:0.010843:0.007807:0.005615:0.011459:0.009861
54,64,65:@0.549087:0.846631:0.590821:0.846631:0.590821:0.834753:0.549087:0.834753:0.006082:0.006082:0.002622:0.006082:0.006082:0.002622:0.006082:0.006082
, assessment of prognosis and :@0.590819:0.854247:0.857048:0.854247:0.857048:0.833874:0.590819:0.833874:0.004497:0.008104:0.009291:0.007533:0.007875:0.009039:0.007533:0.007601:0.017485:0.009039:0.011391:0.006437:0.008104:0.010843:0.006209:0.008104:0.011071:0.007442:0.011048:0.009861:0.011598:0.010955:0.007601:0.005615:0.007670:0.008104:0.009085:0.011596:0.011391:0.004109
risk of relapse:@0.117647:0.874826:0.240818:0.874826:0.240818:0.854453:0.117647:0.854453:0.007807:0.005615:0.007556:0.010523:0.007944:0.010840:0.006209:0.007944:0.007442:0.008948:0.005433:0.008811:0.011185:0.007875:0.009039
66,67:@0.240826:0.867210:0.267775:0.867210:0.267775:0.855332:0.240826:0.855332:0.006082:0.006082:0.002622:0.006082:0.006082
 and minimal residual disease and recurrence monitoring through :@0.267774:0.874826:0.857025:0.874826:0.857025:0.854453:0.267774:0.854453:0.007944:0.009085:0.011596:0.011391:0.007944:0.017645:0.005615:0.011756:0.005615:0.017577:0.009405:0.005250:0.007944:0.007442:0.009039:0.007601:0.005547:0.011048:0.011596:0.009405:0.005250:0.007944:0.011391:0.005615:0.007873:0.009291:0.009291:0.007875:0.009039:0.007944:0.009087:0.011596:0.011391:0.007944:0.007442:0.009108:0.009108:0.011413:0.007807:0.007442:0.009039:0.011596:0.008994:0.009039:0.007944:0.017485:0.010843:0.011756:0.005273:0.006209:0.010843:0.007807:0.005615:0.011459:0.009861:0.007944:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011459:0.004109
serial measurements:@0.117647:0.895404:0.293094:0.895404:0.293094:0.875031:0.117647:0.875031:0.007875:0.009039:0.007807:0.005798:0.009405:0.005250:0.006780:0.017485:0.009291:0.009291:0.007510:0.011413:0.007442:0.009039:0.017485:0.009039:0.011391:0.006437:0.007670
67–69:@0.293091:0.887788:0.324298:0.887788:0.324298:0.875911:0.293091:0.875911:0.006082:0.006082:0.006880:0.006082:0.006082
. The main limitations for further use of ctDNA in the clinic :@0.324297:0.895404:0.857074:0.895404:0.857074:0.875031:0.324297:0.875031:0.004497:0.006780:0.011470:0.011311:0.009039:0.006780:0.017577:0.009085:0.005615:0.011756:0.006780:0.005250:0.005615:0.017645:0.005273:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.006780:0.006026:0.010843:0.007807:0.006780:0.006369:0.011413:0.007967:0.006620:0.011299:0.009039:0.007807:0.006780:0.011413:0.007875:0.009039:0.006780:0.010843:0.006209:0.006780:0.009108:0.006437:0.015773:0.015408:0.014929:0.006780:0.005615:0.011756:0.006780:0.006620:0.011299:0.009039:0.006780:0.008765:0.005250:0.005615:0.011756:0.005547:0.008994:0.004109
relate to the variation in ctDNA levels and VAF between patients:@0.117647:0.915983:0.672977:0.915983:0.672977:0.895610:0.117647:0.895610:0.007442:0.008948:0.005433:0.008811:0.006209:0.009039:0.005547:0.006209:0.011048:0.005547:0.006620:0.011299:0.009039:0.005547:0.009838:0.009087:0.007807:0.005796:0.008811:0.006437:0.005547:0.010843:0.011756:0.005547:0.005615:0.011756:0.005547:0.009108:0.006437:0.015773:0.015408:0.014929:0.005547:0.005182:0.009334:0.009635:0.008946:0.005250:0.007670:0.005547:0.009085:0.011598:0.011391:0.005547:0.012578:0.014929:0.011276:0.005547:0.011254:0.009131:0.006437:0.014518:0.009108:0.009039:0.011756:0.005547:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.007670
57,59:@0.673040:0.908367:0.699989:0.908367:0.699989:0.896490:0.673040:0.896490:0.006082:0.006082:0.002622:0.006082:0.006082
 and confounding :@0.699988:0.915983:0.857036:0.915983:0.857036:0.895610:0.699988:0.895610:0.005547:0.009085:0.011596:0.011391:0.005547:0.008994:0.010843:0.011756:0.006026:0.010820:0.011413:0.011596:0.011391:0.005615:0.011459:0.009861:0.004109